172 results on '"Cannalire, Rolando"'
Search Results
2. Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination
3. Easy access to α-ketoamides as SARS-CoV-2 and MERS Mpro inhibitors via the PADAM oxidation route
4. Evolution of HCV NS4B Inhibitors
5. Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation
6. Special Issue “Advances in Antiviral Agents against SARS-CoV-2 and Its Variants”
7. A Focus on Severe Acute Respiratory Syndrome ( <scp>SARS</scp> ) Coronavirus ( <scp>SARS‐CoVs</scp> ) 1 and 2
8. Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses
9. Author Reply to Peer Reviews of Nirmatrelvir treatment blunts the development of antiviral adaptive immune responses in SARS-CoV-2 infected mice
10. Isocyanide chemistry enabled by continuous flow technology
11. Nirmatrelvir treatment blunts the development of antiviral adaptive immune responses in SARS-CoV-2 infected mice
12. Isocyanide Chemistry Enabled by Continuous Flow Technology
13. An overview on small molecules acting as broad-spectrum agents for yellow fever infection
14. Domino synthesis of 5-aminoimidazoles from Strecker multicomponent adducts via ytterbium-promoted isocyanide insertion/5-exo-dig cyclization
15. Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities
16. Visible-light photocatalytic metal-free multicomponent Ugi-like chemistry
17. A Focus on Severe Acute Respiratory Syndrome ( SARS ) Coronavirus ( SARS‐CoVs ) 1 and 2
18. Photomicellar Catalyzed Synthesis of Amides from Isocyanides: Optimization, Scope, and NMR Studies of Photocatalyst/Surfactant Interactions
19. The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors
20. Visible-Light Photocatalytic Ugi/Aza-Wittig Cascade towards 2-Aminomethyl-1,3,4-oxadiazole Derivatives
21. From Quinoline to Quinazoline‐Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search
22. Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi
23. Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen
24. Visible light photocatalysis in the late-stage functionalization of pharmaceutically relevant compounds
25. Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a small molecule in-vitro repurposing screen
26. Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
27. Broad‐Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View
28. Visible-Light Photocatalytic Functionalization of Isocyanides for the Synthesis of Secondary Amides and Ketene Aminals
29. Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.
30. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors
31. SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells
32. Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase
33. C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors
34. Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones
35. Visible-Light Photocatalytic Ugi/Aza-Wittig Cascade towards 2-Aminomethyl-1,3,4-oxadiazole Derivatives.
36. Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position
37. Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase
38. Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium
39. Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions
40. Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants
41. Design and Synthesis of WM5 Analogues as HIV-1 TAR RNA Binders
42. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction
43. Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones
44. Cover Picture: Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues (ChemMedChem 16/2017)
45. Searching for Novel Inhibitors of theS. aureusNorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues
46. Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R againstEscherichia coli
47. Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor
48. Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization
49. A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates
50. Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.